DoseFinding (Q20204): Difference between revisions
From MaRDI portal
Changed an Item |
Swh import (talk | contribs) SWHID from Software Heritage |
||||||||||||||
| (5 intermediate revisions by 4 users not shown) | |||||||||||||||
| Property / depends on software | |||||||||||||||
| Property / depends on software: R / rank | |||||||||||||||
| Property / depends on software: R / qualifier | |||||||||||||||
| Property / depends on software | |||||||||||||||
| Property / depends on software: R / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / depends on software: R / qualifier | |||||||||||||||
software version identifier: ≥ 2.15.0 | |||||||||||||||
| Property / MaRDI profile type | |||||||||||||||
| Property / MaRDI profile type: MaRDI software profile / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / source code repository | |||||||||||||||
| Property / source code repository: https://github.com/cran/DoseFinding / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Software Heritage ID | |||||||||||||||
| Property / Software Heritage ID: swh:1:snp:8318fbe0892bdb74bbfeb2aa6e4c4dacd877dc68 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Software Heritage ID: swh:1:snp:8318fbe0892bdb74bbfeb2aa6e4c4dacd877dc68 / qualifier | |||||||||||||||
| Property / Software Heritage ID: swh:1:snp:8318fbe0892bdb74bbfeb2aa6e4c4dacd877dc68 / qualifier | |||||||||||||||
point in time: 9 November 2023
| |||||||||||||||
| links / mardi / name | links / mardi / name | ||||||||||||||
Latest revision as of 15:56, 21 March 2024
Planning and Analyzing Dose Finding Experiments
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DoseFinding |
Planning and Analyzing Dose Finding Experiments |
Statements
2 November 2023
0 references
The DoseFinding package provides functions for the design and analysis of dose-finding experiments (with focus on pharmaceutical Phase II clinical trials). It provides functions for: multiple contrast tests, fitting non-linear dose-response models (using Bayesian and non-Bayesian estimation), calculating optimal designs and an implementation of the MCPMod methodology (Pinheiro et al. (2014) <doi:10.1002/sim.6052>).
0 references
